repository
BROWSE
Cited 0 times in 
Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: the role of interleukin-17 suppression?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, SJ | - |
| dc.contributor.author | Shin, JI | - |
| dc.date.accessioned | 2014-05-23 | - |
| dc.date.available | 2014-05-23 | - |
| dc.date.issued | 2013 | - |
| dc.identifier.issn | 0300-9475 | - |
| dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/10089 | - |
| dc.language.iso | en | - |
| dc.subject.MESH | Animals | - |
| dc.subject.MESH | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | - |
| dc.subject.MESH | Antibodies, Monoclonal, Murine-Derived | - |
| dc.subject.MESH | Humans | - |
| dc.subject.MESH | Immunologic Factors | - |
| dc.subject.MESH | Interleukin-17 | - |
| dc.subject.MESH | Mice | - |
| dc.subject.MESH | Th17 Cells | - |
| dc.title | Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: the role of interleukin-17 suppression? | - |
| dc.type | Article | - |
| dc.identifier.pmid | 23298391 | - |
| dc.identifier.url | http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0300-9475&date=2013&volume=77&issue=3&spage=221 | - |
| dc.contributor.affiliatedAuthor | 박, 세진 | - |
| dc.type.local | Journal Papers | - |
| dc.identifier.doi | 10.1111/sji.12025 | - |
| dc.citation.title | Scandinavian journal of immunology | - |
| dc.citation.volume | 77 | - |
| dc.citation.number | 3 | - |
| dc.citation.date | 2013 | - |
| dc.citation.startPage | 221 | - |
| dc.citation.endPage | 221 | - |
| dc.identifier.bibliographicCitation | Scandinavian journal of immunology, 77(3). : 221-221, 2013 | - |
| dc.identifier.eissn | 1365-3083 | - |
| dc.relation.journalid | J003009475 | - |
- Appears in Collections:
- Journal Papers > School of Medicine / Graduate School of Medicine > Pediatrics & Adolescent Medicine
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
